Literature DB >> 2663823

Immunology and cellular biology of Hodgkin's disease.

D J Slivnick1, J F Nawrocki, R I Fisher.   

Abstract

Patients with Hodgkin's disease, either untreated or in remission, exhibit a persistent defect in cellular immunity. This cellular immune defect appears to be the result of increased sensitivity to suppressor monocytes and T-suppressor cells, in addition to abnormal Interleukin-2 production. T-lymphocyte function is abnormal in patients with advanced disease. The precise origin of Reed-Sternberg and Hodgkin's cells is unknown. Reed-Sternberg cells function as antigen-presenting cells and as accessory cells in mitogen-induced T-cell proliferation. They have properties in common with dendritic cells and activated lymphocytes. L428 cells express a transformation-associated phosphorylated transmembrane protein, with properties of a growth factor receptor, that may play a role in tumorigenic transformation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2663823

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  6 in total

1.  bcl-2 rearrangement in Hodgkin's disease. Results of polymerase chain reaction, flow cytometry, and sequencing on formalin-fixed, paraffin-embedded tissue.

Authors:  A H Reid; R E Cunningham; G Frizzera; T J O'Leary
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

2.  Inconsistency of the immunophenotype of Reed-Sternberg cells in simultaneous and consecutive specimens from the same patients. A paraffin section evaluation in 56 patients.

Authors:  W S Chu; S L Abbondanzo; G Frizzera
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

3.  Detection of Epstein-Barr virus sequences in Hodgkin's disease by the polymerase chain reaction.

Authors:  C F Wright; A H Reid; M M Tsai; K M Ventre; P J Murari; G Frizzera; T J O'Leary
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

Review 4.  Human papillomavirus vaccination in survivors of childhood cancer.

Authors:  James L Klosky; Heather L Gamble; Sheri L Spunt; Mary E Randolph; Daniel M Green; Melissa M Hudson
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

5.  Successful treatment in a child with anaplastic large cell lymphoma and coexistence of pulmonary tuberculosis.

Authors:  Margarita Baka; Dimitrios Doganis; Apostolos Pourtsidis; Maria Tsolia; Despina Bouhoutsou; Maria Varvoutsi; Katerina Strantzia; Helen Kosmidis
Journal:  Case Rep Pediatr       Date:  2013-06-13

6.  Mutagenesis after cancer therapy.

Authors:  K T Kelsey; M Caggana; P M Mauch; C N Coleman; J R Clark; H L Liber
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.